Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47K Sell
26
-63
-71% -$13.5K ﹤0.01% 1245
2026
Q1
$19.7K Buy
89
+46
+107% +$11.3K ﹤0.01% 801
2025
Q4
$10.9K Sell
43
-3
-7% -$753 ﹤0.01% 784
2025
Q3
$11.4K Buy
46
+7
+18% +$1.68K ﹤0.01% 784
2025
Q2
$9.37K Sell
39
-16
-29% -$3.73K ﹤0.01% 808
2025
Q1
$12.5K Buy
55
+29
+112% +$6.38K ﹤0.01% 762
2024
Q4
$5.34K Buy
26
+9
+53% +$1.97K ﹤0.01% 875
2024
Q3
$4.12K Buy
17
+1
+6% +$234 ﹤0.01% 875
2024
Q2
$3.51K Buy
16
+1
+7% +$217 ﹤0.01% 879
2024
Q1
$3.37K Hold
15
﹤0.01% 878
2023
Q4
$3.3K Buy
+15
New +$3.17K ﹤0.01% 855
2023
Q3
Sell
-35
Closed -$7.87K 847
2023
Q2
$7.87K Buy
35
+20
+133% +$4K ﹤0.01% 747
2023
Q1
$2.87K Buy
15
+5
+50% +$966 ﹤0.01% 833
2022
Q4
$1.85K Sell
10
-15
-60% -$2.64K ﹤0.01% 833
2022
Q3
$4K Sell
25
-185
-88% -$37.6K ﹤0.01% 753
2022
Q2
$43K Buy
210
+115
+121% +$25.9K 0.01% 401
2022
Q1
$23K Buy
95
+65
+217% +$15.1K 0.01% 537
2021
Q4
$7K Buy
+30
New +$6.85K ﹤0.01% 706
2021
Q3
Sell
-25
Closed -$5K 814
2021
Q2
$5K Hold
25
﹤0.01% 775
2021
Q1
$5K Buy
+25
New +$4.64K ﹤0.01% 631

Other funds holding STE

CVA Family Office's STE Position: Q2 2026 in Review

CVA Family Office reduced its Steris (STE) stake by 71% in Q2 2026, selling an estimated $13.5K and leaving 26 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

CVA Family Office first reported a position in STE in Q1 2021 and has held it in 20 quarters since. The position peaked at $43K in Q2 2022. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • CVA Family Office held 26 shares of Steris worth $5.47K as of Q2 2026.
  • CVA Family Office sold 63 Steris shares in Q2 2026, an estimated $13.5K.
  • Steris made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1245 holding.
  • CVA Family Office first reported a position in Steris in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Steris position peaked at $43K in Q2 2022.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.